Pune, India, February 2022/MRFR Press Release/- Market Research Future has published a half-cooked research report on the global platelet aggregation devices market.
The Platelet Aggregation Devices Market is expected to reach USD 2284.51Million by 2030 at 21.50% CAGR during the forecast period 2022-2030.
Platelet aggregation is the platelet-to-platelet adhesion in the blood to form blood clots. Few of the major market growth factors are the globally growing geriatric population coupled with rising prevalence of target diseases, surging number of industry-academia collaborations and clinical studies, and increasing technological advancements in platelet aggregometers such as 96-well plate-based aggregometry. According to the World Health Organization (WHO), in 2017, the worldwide population aged 60 years and above was 962.0 million, which is projected to increase to more than 2.0 billion by 2050 and further would reach to 3.1 billion by 2100.
The global platelet aggregation devices market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On the basis of region, the Americas is likely to spearhead the global platelet aggregation devices market. This is due to the presence of device manufacturers, rising prevalence of orthopedic, urological, and bleeding disorders, surging number of cardiovascular surgeries, and increasing incidence of blood disorders. For instance, as per the data provided by the National Hemophilia Foundation, currently, hemophilia A occurs in 1 in 5,000 live male births in US which is about four times as common as hemophilia B. At present, the number of individuals suffering from hemophilia in the US is around 20,000.
Europe is also expected to hold substantial market share over the forecast period due to large population base which is suffering from cardiovascular diseases, neoplasms, and strokes, the domicile of device manufacturers such as Siemens Healthineers, F. Hoffmann-La Roche Ltd, Sentinel CH. SpA, and Haemochrom Diagnostica GmbH and the development of affordable platelet function tests by the manufacturers.
The market in Asia-Pacific is expected to register comparatively higher CAGR over the forecast period owing to growing geriatric population coupled with rising prevalence of chronic diseases and platelet disorders, and rising incidences of mosquito-borne diseases such as malaria and dengue.
The Middle East & Africa has the least share of the global platelet aggregation devices market. Additionally, the major market share of the region would be held by the Middle East region due to improving quality healthcare in the Middle East.
Explore In-depth Market Details [Table of Content, List of Figures, List of Tables] of Platelet Aggregation Devices Market Research Report
The global platelet aggregation devices market has been segmented into product, application, and end user.
By product, the market has been segmented into systems, reagents, and consumables and accessories.
On the basis of application, the market has been divided into clinical applications and research applications. The clinical applications segment is further sub-segmented into cardiovascular applications, orthopedic applications, and others.
Based on end user, the market has been categorized into hospitals and clinics, diagnostic laboratories, research and academic institutes, and others.
Some of the foremost players in the global platelet aggregation devices market are Siemens Healthineers, F. Hoffmann-La Roche Ltd, Sentinel CH. SpA, Sysmex Corporation, Werfen, Helena Laboratories, Bio/Data Corporation, Haemonetics Corporation, AggreDyne, Inc., Haemochrom Diagnostica GmbH, and Pathway Diagnostics Limited.